Evaluation of markers of outcome in real-world treatment of diabetic macular edema

Detalhes bibliográficos
Autor(a) principal: Campos, António
Data de Publicação: 2018
Outros Autores: Campos, Elisa J., Carmo, Anália do, Caramelo, Francisco, Martins, João, Sousa, João P., Ambrósio, António, Silva, Rufino
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10316/107595
https://doi.org/10.1186/s40662-018-0119-9
Resumo: Objective: To evaluate short-term markers of outcome in diabetic macular edema (DME). Methods: Prospective interventional case series included 122 eyes of 122 patients with recently diagnosed DME. Eyes were treated with a 3-monthly loading dose of ranibizumab or aflibercept and pro re nata thereafter. Serial enhanced deep imaging SD-OCT high resolution scans were used to measure subfoveal choroidal thickness (SFCT) and central retinal thickness (CRT). Anatomic (10% CRT decrease) and functional responses (best corrected visual acuity, BCVA gain ≥5 letters) were assessed at 3 months and 6 months using univariate and multivariate analyses. Parameters tested were gender, duration of diabetes, HbA1c, hypertension, CRT, SFCT, BCVA, ellipsoid zone (EZ) status, subfoveal neuroretinal detachment (SND), anti-VEGF used and laser naivety. A logistic regression model was applied to find independent markers outcome. Results: BCVA increased, CRT and SFCT decreased at 3 months and 6 months. Good metabolic control (p = 0.003), intact baseline EZ (p = 0.030), EZ re-grading at 3 M (p < 0.001) and laser naivety (p = 0.001) were associated with better functional outcome. The multivariate linear regression model showed that baseline SND and CRT are predictors of anatomic response, while lower baseline BCVA and intact EZ are predictors of functional response. Conclusion: The presence of SND predicts anatomic response only, while an intact EZ is critical to achieve a good functional outcome in DME.
id RCAP_fe3c5a31eca20ab08bb49b7fb5cc81df
oai_identifier_str oai:estudogeral.uc.pt:10316/107595
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Evaluation of markers of outcome in real-world treatment of diabetic macular edemaDiabetic macular edemaOutcome factorsSpectral-domain optical coherence tomographyAntivascular endothelial growth factorLaserObjective: To evaluate short-term markers of outcome in diabetic macular edema (DME). Methods: Prospective interventional case series included 122 eyes of 122 patients with recently diagnosed DME. Eyes were treated with a 3-monthly loading dose of ranibizumab or aflibercept and pro re nata thereafter. Serial enhanced deep imaging SD-OCT high resolution scans were used to measure subfoveal choroidal thickness (SFCT) and central retinal thickness (CRT). Anatomic (10% CRT decrease) and functional responses (best corrected visual acuity, BCVA gain ≥5 letters) were assessed at 3 months and 6 months using univariate and multivariate analyses. Parameters tested were gender, duration of diabetes, HbA1c, hypertension, CRT, SFCT, BCVA, ellipsoid zone (EZ) status, subfoveal neuroretinal detachment (SND), anti-VEGF used and laser naivety. A logistic regression model was applied to find independent markers outcome. Results: BCVA increased, CRT and SFCT decreased at 3 months and 6 months. Good metabolic control (p = 0.003), intact baseline EZ (p = 0.030), EZ re-grading at 3 M (p < 0.001) and laser naivety (p = 0.001) were associated with better functional outcome. The multivariate linear regression model showed that baseline SND and CRT are predictors of anatomic response, while lower baseline BCVA and intact EZ are predictors of functional response. Conclusion: The presence of SND predicts anatomic response only, while an intact EZ is critical to achieve a good functional outcome in DME.Springer Nature2018info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articlehttp://hdl.handle.net/10316/107595http://hdl.handle.net/10316/107595https://doi.org/10.1186/s40662-018-0119-9eng2326-025430386806Campos, AntónioCampos, Elisa J.Carmo, Anália doCaramelo, FranciscoMartins, JoãoSousa, João P.Ambrósio, AntónioSilva, Rufinoinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-07-21T10:05:40Zoai:estudogeral.uc.pt:10316/107595Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T21:23:55.846566Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Evaluation of markers of outcome in real-world treatment of diabetic macular edema
title Evaluation of markers of outcome in real-world treatment of diabetic macular edema
spellingShingle Evaluation of markers of outcome in real-world treatment of diabetic macular edema
Campos, António
Diabetic macular edema
Outcome factors
Spectral-domain optical coherence tomography
Antivascular endothelial growth factor
Laser
title_short Evaluation of markers of outcome in real-world treatment of diabetic macular edema
title_full Evaluation of markers of outcome in real-world treatment of diabetic macular edema
title_fullStr Evaluation of markers of outcome in real-world treatment of diabetic macular edema
title_full_unstemmed Evaluation of markers of outcome in real-world treatment of diabetic macular edema
title_sort Evaluation of markers of outcome in real-world treatment of diabetic macular edema
author Campos, António
author_facet Campos, António
Campos, Elisa J.
Carmo, Anália do
Caramelo, Francisco
Martins, João
Sousa, João P.
Ambrósio, António
Silva, Rufino
author_role author
author2 Campos, Elisa J.
Carmo, Anália do
Caramelo, Francisco
Martins, João
Sousa, João P.
Ambrósio, António
Silva, Rufino
author2_role author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Campos, António
Campos, Elisa J.
Carmo, Anália do
Caramelo, Francisco
Martins, João
Sousa, João P.
Ambrósio, António
Silva, Rufino
dc.subject.por.fl_str_mv Diabetic macular edema
Outcome factors
Spectral-domain optical coherence tomography
Antivascular endothelial growth factor
Laser
topic Diabetic macular edema
Outcome factors
Spectral-domain optical coherence tomography
Antivascular endothelial growth factor
Laser
description Objective: To evaluate short-term markers of outcome in diabetic macular edema (DME). Methods: Prospective interventional case series included 122 eyes of 122 patients with recently diagnosed DME. Eyes were treated with a 3-monthly loading dose of ranibizumab or aflibercept and pro re nata thereafter. Serial enhanced deep imaging SD-OCT high resolution scans were used to measure subfoveal choroidal thickness (SFCT) and central retinal thickness (CRT). Anatomic (10% CRT decrease) and functional responses (best corrected visual acuity, BCVA gain ≥5 letters) were assessed at 3 months and 6 months using univariate and multivariate analyses. Parameters tested were gender, duration of diabetes, HbA1c, hypertension, CRT, SFCT, BCVA, ellipsoid zone (EZ) status, subfoveal neuroretinal detachment (SND), anti-VEGF used and laser naivety. A logistic regression model was applied to find independent markers outcome. Results: BCVA increased, CRT and SFCT decreased at 3 months and 6 months. Good metabolic control (p = 0.003), intact baseline EZ (p = 0.030), EZ re-grading at 3 M (p < 0.001) and laser naivety (p = 0.001) were associated with better functional outcome. The multivariate linear regression model showed that baseline SND and CRT are predictors of anatomic response, while lower baseline BCVA and intact EZ are predictors of functional response. Conclusion: The presence of SND predicts anatomic response only, while an intact EZ is critical to achieve a good functional outcome in DME.
publishDate 2018
dc.date.none.fl_str_mv 2018
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10316/107595
http://hdl.handle.net/10316/107595
https://doi.org/10.1186/s40662-018-0119-9
url http://hdl.handle.net/10316/107595
https://doi.org/10.1186/s40662-018-0119-9
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 2326-0254
30386806
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Springer Nature
publisher.none.fl_str_mv Springer Nature
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799134125206011904